Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors

Clinical trial NCT03693846 · TERMINATED

Trial details

NCT number: NCT03693846
Sponsor: Abramson Cancer Center at Penn Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Mucinous Adenocarcinoma of the Colon Mucinous Adenocarcinoma of the Rectum

Start date: 2019-02-15
Primary completion: 2021-03-06
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.